More Clinical Articles

Clinical

Doctors views on online networks and e-Detailing

Alexandra Uprichard, (Jun 21, 2011)

The Internet has become an integral part of the healthcare conversation, presenting opportunities for sharing, developing and educating. Pharma, while somewhat impeded by ambiguous regulation, is exploring how to take advantage of these opportunities.
Commercial

Market access: Negotiating the new landscape for oncology

Peter Mansell, (Jan 25, 2011)

*Peter Mansell explores how the boom in cancer drug development conflicts with current healthcare funding models *
Commercial

Social media: A tool for clinical trial recruitment?

Andrew Tolve, (Jan 4, 2011)

Clinical

Personalized Medicine March 2011

adaptive, (Jan 1, 2011)

eyeforpharma has recently developed a landmark event to be held in London on 9th/10th March focusing on the increasingly topical Personalized Medicine.
Commercial

Personalized medicine: A kick-start for innovation?

Angelo DePalma, (Dec 8, 2010)

*Angelo DePalma reports on how personalized medicine may further weaken the blockbuster model of drug development but open up lucrative new niche markets*
Commercial

Forecasting for orphan drugs: The data challenge

Angelo DePalma, (Jul 8, 2010)

Gianclaudio Floria, senior manager for business planning and analysis at Amgen, on best practice in forecasting for orphan drug development.
Clinical

The patients role in medicine taking

Anonymous (not verified), (Aug 11, 2009)

Despite protracted effort invested in drug development, pharma leaves what happens once its product reaches the patient to chance, says Theo Raynor, professor of pharmacy practice at the University of Leeds and executive chairman of LUTO Research.
Commercial

The future of pharma marketing

Anonymous (not verified), (Jun 18, 2008)

The pharmaceutical industry has undergone significant changes and restructuring that have caused the sales force to downsize and reorganize, and research and development teams to reconsider the blockbuster approach to new drug development. With these changes, marketers must also change and adapt to new market realities.
Clinical

The Solution to More Effective Clinical Trials: Adherence Packaging

Anonymous (not verified), (Jun 5, 2008)

Patient adherence is critical in a clinical trial setting -- it has a direct impact on the validity of clinical trial data, an issue of utmost importance to pharmaceutical manufacturers, as well as the scientific and regulatory community. While adherence is influenced by a variety of factors, packaging has proven to play an important role in improving compliance rates.
Clinical

Impact of adaptive trials on the pharma IT landscape

Editor, (Oct 30, 2007)

Adaptive clinical trials have the potential to lower cost, reduce time to market and increase patient safety.

Pages